Finally, while increasing evidence supports the importance of DDAH in the regulation of NO bioactivity through ADMA metabolism in cardiovascular disease [20], [44], the direct effects of DDAH2-induced changes in intracellular ADMA concentration on NO bioactivity and outcomes in sepsis has not been adequately studied. This evidence concerns the gene DDAH1 and cardiovascular disorder.